Home / Data / Recall & Adverse Event Monitor Recall & Adverse Event Monitor Recall & Adverse Event Monitor organizes records from openFDA API into a static ledger for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 2,000
Last changed 08/30/2026
Update schedule 28 2 * * 4 UTC
Coverage 06/30/2026–06/30/2026 2026-06-30
Title ENBREL
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title REPATHA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TARLATAMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title FINASTERIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OCREVUS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title HERCEPTIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ONGENTYS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NUPLAZID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NUPLAZID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NUPLAZID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RITUXIMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title PROLIA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NUPLAZID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CARBOPLATIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title WEGOVY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title LUMAKRAS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title WEGOVY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title BEVACIZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title PLUVICTO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title GOLIMUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title WEGOVY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VEOZAH
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ISOTRETINOIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title METFORMIN HYDROCHLORIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DAPAGLIFLOZIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TRUXIMA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NINTEDANIB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VABYSMO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title WEGOVY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title EKTERLY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ADEMPAS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SEVOFLURANE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title FOSCAVIR
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title MELPHALAN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RISANKIZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title POMALIDOMIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title IMDELLTRA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ADALIMUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SKYRIZI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OBINUTUZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24 Source U.S. Food and Drug Administration, openFDA API · official record · retrieved 08/30/2026 · upstream last modified 08/30/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. Food and Drug Administration
Required notice Reports do not prove causation and are not medical advice, diagnosis, or an assessment of individual risk. What we add We compute Event Classification, Age Or Deadline Days, Public Significance Score using the documented compute method. · methodology